Cargando…
No Evidence for Acquired Mutations Associated with Cytochrome bc(1) Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates
Autores principales: | Rybniker, Jan, Kohl, Thomas Andreas, Barilar, Ivan, Niemann, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325196/ https://www.ncbi.nlm.nih.gov/pubmed/30323041 http://dx.doi.org/10.1128/AAC.01317-18 |
Ejemplares similares
-
Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015) -
Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNP
por: Dreyer, Viola, et al.
Publicado: (2020) -
Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex
por: Merker, Matthias, et al.
Publicado: (2020) -
Transmission Dynamics of a Mycobacterium tuberculosis Complex Outbreak in an Indigenous Population in the Colombian Amazon Region
por: Pérez-Llanos, Francy J., et al.
Publicado: (2023) -
SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc
(1) inhibitors
por: Phummarin, Narisa, et al.
Publicado: (2016)